Country: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Marbofloxacin
Krka, d.d., Novo mesto
QJ01MA93
Marbofloxacin
20 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Cattle, Dogs, Pigs
marbofloxacin
Antibacterial
Authorised
2011-08-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Marfloxin 20 mg/ml solution for injection for calves, pigs, dogs and cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Marbofloxacin 20 mg EXCIPIENTS: Metacresol 2 mg Disodium edetate 0.10 mg Monothioglycerol 0.50 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Calves (pre-ruminant and ruminant), pigs, dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of infections due to marbofloxacin susceptible strains of bacteria. In Calves Treatment of respiratory infections caused by_ Histophilus somni, Mannheimia haemolytica_ and_ Pasteurella multocida._ In Pigs Treatment of respiratory infections. Treatment of Metritis Mastitis Agalactia (MMA) syndrome. In Dogs Treatment of infected wounds and abscesses. Treatment of lower urinary tract infections due to_ Escherichia coli_ and_ Proteus mirabilis._ Prevention of surgical infections due to_ Staphylococcus intermedius, Escherichia coli_ and_ Pseudomonas aeruginosa_. In Cats Treatment of infected wounds and abscesses. Prevention of surgical infections due to_ Staphylococcus intermedius, Escherichia coli_ and_ Pseudomonas aeruginosa_. 4.3 CONTRAINDICATIONS Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a Прочитајте комплетан документ